# Ken Greenberg

> Ken Greenberg is a Series B investor at Venrock Healthcare Capital Partners backing Medical. See 2 investments, check sizes, portfolio and contact details…

- Type: Angel Investor
- Fund: [Venrock Healthcare Capital Partners](https://shizune.co/investors/profile/venrock-healthcare-partners)
- Location: New City, United States
- Total investments: 2
- Last investment: May 2026
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/ken-greenberg-23ab21

Ken Greenberg is a Series B investor at Venrock Healthcare Capital Partners in New City focused on Medical and Biotechnology. Ken Greenberg

## Contacts

5 contacts available for Ken Greenberg: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/ken-greenberg-548b?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 100% |
| Biotechnology | 2 | 100% |
| Health Care | 1 | 50% |
| Therapeutics | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 50% |
| Series D | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 1 | 50% |
| United Kingdom | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| CellCentric | CellCentric’s primary programme targets a deubiquitinase (DUB) enzyme which is strongly associated with prostate cancer, a leading cause of mortality among men. The target modulates the androgen receptor pathway and can potentially combat the multiple resistance mechanisms seen with recently approved prostate cancer drugs such Xtandi and Zytiga.The programme also has potential clinical utility in non-small cell lung, breast and colon cancer. | $220M | Series D | May 06, 2026 |  |
| AIRNA | AIRNA is a biotech company that is pioneering RNA editing therapies to improve the health of individuals suffering from both rare and common ailments. | $155M | Series B | Apr 01, 2025 |  |

2 of 2 investments shown.

## Co-investors
- [Forbion Capital Partners](https://shizune.co/investors/profile/forbion-capital-partners) — VC Fund, 3 deals together
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund, 1 deal together
- [Avego Bioscience Capital](https://shizune.co/investors/profile/avego-bioscience-capital) — VC Fund, 1 deal together
- [BrightEdge - American Cancer Society](https://shizune.co/investors/profile/brightedge-american-cancer-society) — VC Fund, 1 deal together
- [Fidelity](https://shizune.co/investors/profile/fidelity-investments) — VC Fund, 1 deal together
- [HBM Healthcare Investments](https://shizune.co/investors/profile/hbm-healthcare-investments-ag) — VC Fund, 1 deal together

## About Venrock Healthcare Capital Partners

VC Fund · Palo Alto, United States

Venrock Healthcare Capital Partners is a fund dedicated to investing in publicly-held and privately-held healthcare companies. It leverages its venture expertise, rigorous data analysis, and long-term supportive orientation to support successful biotechnology companies within the public markets. The company is headquartered in Palo Alto,California with an office in New York, New York.

1 contacts available at Venrock Healthcare Capital Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Ken Greenberg | Partner | — |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Ken Greenberg invest in?

Ken Greenberg invests primarily in Medical, Biotechnology and Health Care startups, most often at Series B and Series D stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Ken Greenberg?

Public channels for Ken Greenberg include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Ken Greenberg last invest?

The most recent investment recorded for Ken Greenberg closed in May 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co